Children's Hospital Los Angeles, Los Angeles, CA, United States; Department of Pediatrics, University of Southern California, Los Angeles, CA, United States; The Saban Research Institute, Los Angeles, CA, United States.
Children's Hospital Los Angeles, Los Angeles, CA, United States; Currently University of California San Francisco School of Medicine, San Francisco, CA, United States.
Cytokine. 2023 Sep;169:156310. doi: 10.1016/j.cyto.2023.156310. Epub 2023 Jul 29.
We compare cytokine profiles at the time of initial CSF shunt placement between children who required no subsequent shunt revision surgeries and children requiring repeated CSF shunt revision surgeries for CSF shunt failure. We also describe the cytokine profiles across surgical episodes for children who undergo multiple subsequent revision surgeries.
This pilot study was nested within an ongoing prospective multicenter study collecting CSF samples and clinical data at the time of CSF shunt surgeries since August 2014. We selected cases where CSF was available for children who underwent an initial CSF shunt placement and had no subsequent shunt revision surgeries during >=24 months of follow-up (n = 7); as well as children who underwent an initial CSF shunt placement and then required repeated CSF shunt revision surgeries (n = 3). Levels of 92 human cytokines were measured using the Olink immunoassay and 41 human cytokines were measured using Luminex based bead array on CSF obtained at the time of each child's initial CSF shunt placement and were displayed in heat maps.
Qualitatively similar profiles for the majority of cytokines were observed among the patients in each group in both Olink and Luminex assays. Lower levels of MCP-3, CASP-8, CD5, CXCL9, CXCL11, eotaxin, IFN-γ, IL-13, IP-10, and OSM at the time of initial surgery were noted in the children who went on to require multiple surgeries. Pro- and anti-inflammatory cytokines were selected a priori and shown across subsequent revision surgeries for the 3 patients. Cytokine patterns differed between patients, but within a given patient pro-inflammatory and anti-inflammatory cytokines acted in a parallel fashion, with the exception of IL-4.
Heat maps of cytokine levels at the time of initial CSF shunt placement for each child undergoing only a single initial CSF shunt placement and for each child undergoing repeat CSF shunt revision surgeries demonstrated qualitatively similar profiles for the majority of cytokines. Lower levels of MCP-3, CASP-8, CD5, CXCL9, CXCL11, eotaxin, IFN-γ, IL-13, IP-10, and OSM at the time of initial surgery were noted in the children who went on to require multiple surgeries. Better stratification by patient age, etiology, and mechanism of failure is needed to develop a deeper understanding of the mechanism of inflammation in the development of hydrocephalus and response to shunting in children.
我们比较了初始 CSF 分流放置时细胞因子谱在不需要后续分流修复手术和需要多次 CSF 分流修复手术以治疗 CSF 分流失败的儿童之间的差异。我们还描述了多次后续修复手术后儿童的手术期间细胞因子谱。
这项试点研究是在 2014 年 8 月开始进行的一项正在进行的前瞻性多中心研究中进行的,该研究在 CSF 分流手术时收集 CSF 样本和临床数据。我们选择了在 24 个月以上的随访期间没有进行后续分流修复手术的初次 CSF 分流放置儿童(n=7),以及初次 CSF 分流放置后需要多次 CSF 分流修复手术的儿童(n=3),并在这些儿童初次 CSF 分流放置时获得 CSF 样本,使用 Olink 免疫测定法测量 92 种人类细胞因子的水平,使用 Luminex 基于 bead array 测量 41 种人类细胞因子的水平,并以热图形式显示。
在 Olink 和 Luminex 检测中,每组患者的大多数细胞因子都表现出定性相似的特征。在需要多次手术的儿童中,初次手术时 MCP-3、CASP-8、CD5、CXCL9、CXCL11、嗜酸性粒细胞趋化因子、IFN-γ、IL-13、IP-10 和 OSM 的水平较低。在 3 名患者中,选择了前炎性和抗炎性细胞因子,并在随后的多次手术中显示。细胞因子模式在患者之间存在差异,但在同一患者中,前炎性和抗炎性细胞因子以平行的方式起作用,除了 IL-4 以外。
每个仅接受单次初始 CSF 分流放置的儿童和每个接受重复 CSF 分流修复手术的儿童在初始 CSF 分流放置时的细胞因子水平热图显示,大多数细胞因子的特征相似。在需要多次手术的儿童中,初次手术时 MCP-3、CASP-8、CD5、CXCL9、CXCL11、嗜酸性粒细胞趋化因子、IFN-γ、IL-13、IP-10 和 OSM 的水平较低。需要根据患者年龄、病因和失败机制进行更好的分层,以更深入地了解儿童脑积水发展和分流反应中炎症的机制。